DD143772A5 - Verfahren zur herstellung von neuen thiadiazolderivaten - Google Patents

Verfahren zur herstellung von neuen thiadiazolderivaten Download PDF

Info

Publication number
DD143772A5
DD143772A5 DD79213131A DD21313179A DD143772A5 DD 143772 A5 DD143772 A5 DD 143772A5 DD 79213131 A DD79213131 A DD 79213131A DD 21313179 A DD21313179 A DD 21313179A DD 143772 A5 DD143772 A5 DD 143772A5
Authority
DD
German Democratic Republic
Prior art keywords
group
formula
sub
sup
carbon atoms
Prior art date
Application number
DD79213131A
Other languages
German (de)
English (en)
Inventor
Tobias O Yellin
Derrick M Mant
Original Assignee
Ici Ltd
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd, Ici America Inc filed Critical Ici Ltd
Publication of DD143772A5 publication Critical patent/DD143772A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DD79213131A 1978-05-24 1979-05-24 Verfahren zur herstellung von neuen thiadiazolderivaten DD143772A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2173778 1978-05-24

Publications (1)

Publication Number Publication Date
DD143772A5 true DD143772A5 (de) 1980-09-10

Family

ID=10167957

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79213131A DD143772A5 (de) 1978-05-24 1979-05-24 Verfahren zur herstellung von neuen thiadiazolderivaten

Country Status (22)

Country Link
US (2) US4242350A (cs)
EP (1) EP0006679B1 (cs)
JP (1) JPS54160376A (cs)
AT (1) ATE1353T1 (cs)
AU (1) AU529253B2 (cs)
CA (1) CA1124729A (cs)
CS (2) CS207791B2 (cs)
DD (1) DD143772A5 (cs)
DE (1) DE2963363D1 (cs)
DK (1) DK209079A (cs)
ES (3) ES480894A1 (cs)
FI (1) FI791656A (cs)
GR (1) GR73611B (cs)
HU (1) HU179492B (cs)
IE (1) IE48221B1 (cs)
IL (1) IL57388A0 (cs)
NO (1) NO791710L (cs)
NZ (1) NZ190448A (cs)
PL (1) PL118387B1 (cs)
PT (1) PT69651A (cs)
SU (1) SU1037839A3 (cs)
ZA (1) ZA792202B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2963363D1 (en) * 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
EP0014057B1 (en) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
GR71929B (cs) * 1979-11-13 1983-08-19 Ici Ltd
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
EP0059597B1 (en) * 1981-02-27 1986-04-23 Imperial Chemical Industries Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists
US4460584A (en) * 1981-03-13 1984-07-17 Imperial Chemical Industries Plc Nitrogen heterocycles
IN158869B (cs) * 1981-03-18 1987-02-07 Ici Plc
US4463005A (en) * 1981-03-18 1984-07-31 Imperial Chemical Industries Plc Bicyclic guanidines
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4522943A (en) * 1981-05-18 1985-06-11 Bristol-Myers Company Chemical compounds
US4539316A (en) * 1981-05-18 1985-09-03 Bristol-Myers Company Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
US4526973A (en) * 1981-05-18 1985-07-02 Bristol-Myers Company Chemical compounds
US4546188A (en) * 1981-05-18 1985-10-08 Bristol-Myers Company Substituted 1,2-diaminocyclobutene-3,4-diones
US4395553A (en) * 1981-05-18 1983-07-26 Bristol-Myers Company Chemical compounds
EP0067508B1 (en) * 1981-05-18 1985-10-30 Imperial Chemical Industries Plc Amidine derivatives
US4607105A (en) * 1981-05-18 1986-08-19 Bristol-Myers Company 3-cyclobutene-1,2-dione intermediates
GB8419223D0 (en) * 1984-07-27 1984-08-30 Hoechst Uk Ltd Sulphamoylguanidine derivatives
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE842346C (de) * 1950-10-14 1952-06-26 Joachim Dipl-Chem Dr Goerdeler Verfahren zur Darstellung von 5-Amino-1, 2, 4-thiodiazolen
DE955684C (de) * 1953-10-14 1957-01-10 Bayer Ag Verfahren zur Herstellung von 5-Amino-1, 2, 4-thiodiazolen
NL266116A (cs) 1960-06-22
BE758146A (fr) 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1305549A (cs) 1969-10-29 1973-02-07
GB1338169A (en) 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1400319A (en) 1972-04-20 1975-07-16 Smith Kline French Lab Pharmaceutical compositions
GB1397436A (en) 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1398426A (en) 1972-09-05 1975-06-18 Smith Kline French Lab Heterocyclic substituted guanidines
GB1421999A (en) 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
GB1419994A (en) 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB1421792A (en) 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1497260A (en) 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
GB1533380A (en) 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
GB1533379A (en) 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted ureas
GB1531231A (en) 1974-09-02 1978-11-08 Smith Kline French Lab Process for the production of cyanoguanidine derivatives
GB1574214A (en) 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
ZA782129B (en) * 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
DE2963363D1 (en) * 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK209079A (da) 1979-11-25
NO791710L (no) 1979-11-27
ES480894A1 (es) 1980-02-01
PL215764A1 (cs) 1980-06-16
FI791656A (fi) 1979-11-25
GR73611B (cs) 1984-03-26
NZ190448A (en) 1980-12-19
DE2963363D1 (en) 1982-09-09
US4332949A (en) 1982-06-01
PT69651A (en) 1979-06-01
ATE1353T1 (de) 1982-08-15
SU1037839A3 (ru) 1983-08-23
ZA792202B (en) 1980-05-28
AU4711479A (en) 1979-11-29
IE48221B1 (en) 1984-10-31
IL57388A0 (en) 1979-09-30
ES484149A1 (es) 1980-04-16
CA1124729A (en) 1982-06-01
EP0006679B1 (en) 1982-07-21
ES484150A1 (es) 1980-04-16
AU529253B2 (en) 1983-06-02
CS207791B2 (en) 1981-08-31
EP0006679A1 (en) 1980-01-09
JPS54160376A (en) 1979-12-19
PL118387B1 (en) 1981-09-30
HU179492B (en) 1982-10-28
IE790902L (en) 1979-11-24
US4242350A (en) 1980-12-30
CS207790B2 (en) 1981-08-31

Similar Documents

Publication Publication Date Title
DD143772A5 (de) Verfahren zur herstellung von neuen thiadiazolderivaten
DE2344779A1 (de) Cyanguanidine, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2423813A1 (de) 1,1-diaminoaethylenderivate, ihre salze, verfahren zu ihrer herstellung und arzneimittel
DE2433625A1 (de) Harnstoff-derivate, verfahren zu ihrer herstellung und arzneimittel
DE2847792C2 (cs)
DE2344833A1 (de) Guanidine, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3240727A1 (de) Ergolinderivate, verfahren zu deren herstellung sowie pharmazeutische zubereitungen, die diese enthalten
DE2233458A1 (de) Neue chinolinderivate
DE3216843C2 (de) 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD202551A5 (de) Verfahren zur herstellung eines guanidinabkoemmlings
DE69019294T4 (de) Triazolyl-Hydrazidderivate und Verfahren zu ihrer Herstellung.
DE2819874A1 (de) Bisamidine, verfahren zu ihrer herstellung und ihre verwendung als histamin- h tief 2 - receptor-antagonisten
EP0139993A2 (de) Chinazolinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH642663A5 (de) 3,7-disubstituierte 3-cephem-4-carbonsaeure-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel.
CH643849A5 (en) 3,7-Disubstituted 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceuticals containing them
DE1934392C3 (de) Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung
EP0110298B1 (de) Acridanon-Derivate
CH634848A5 (de) Verfahren zur herstellung neuer 7-(n-substituierter 2-phenylglycinamido)-3-substituierte-3-cephem-4-carbonsaeuren.
DE2641129A1 (de) Derivate des 5-aminomethylthiazols, ihr herstellungsverfahren und pharmazeutische zusammensetzungen
DE2208368C3 (de) 1 -Phenyl-S-hydroxy-S-methyltriazene und Verfahren zu ihrer Herstellung
EP0326981A2 (de) 4-Oxo-4H-pyrido[1,2-a]pyrimidin-3-carbonsäureamid-Derivate, deren Herstellung sowie diese Verbindungen enthaltende Arzneimittelpräparate und deren Herstellung
DE2817078A1 (de) Guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
EP0073931B1 (de) Neue Anilino-1,2,3-triazol-Derivate, diese enthaltende Arzneimittel sowie Verfahren zu deren Herstellung und deren Verwendung
DE2453082A1 (de) Substituierte thiazolylharnstoff- beziehungsweise thiazolylthioharnstoffderivate und ihre salze sowie ihre verwendung und verfahren zur herstellung derselben
EP0091641B1 (de) N-substituierte Imidazol-Derivate, ihre Herstellung, diese enthaltende Arzneimittel und ihre Verwendung